Landos Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2020 to Q1 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Landos Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q1 2024.
- Landos Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 6.21M shares, a 4.27% decline year-over-year.
- Landos Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 6.28M shares, a 55.9% increase from 2022.
- Landos Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 4.03M shares, a 89.3% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)